SEC keeps Nasdaq bitcoin options on hold after granting CME review
WASHINGTON, Aug. 3. The Securities and Exchange Commission has kept Nasdaq's bitcoin options on hold while approving a separate review for the Chicago Mercantile Exchange over contracts in the same asset class. CME is arguing the products are commodity option swaps subject exclusively to Commodity Futures Trading Commission oversight, a stance that would remove the SEC from any regulatory role over them.
Key takeaways
- The SEC has kept Nasdaq's bitcoin options on hold while approving a separate review for the Chicago Mercantile Exchange (CME) over contracts in the same asset class.
- CME argues its bitcoin options are commodity option swaps subject exclusively to CFTC oversight, which would remove the SEC from any regulatory role over them.
- The SEC has not publicly explained why it is treating the two cases differently or offered any timeline for Nasdaq's application.
- Nasdaq's application would follow whatever precedent the CME review produces, making the CME proceeding a reference point for the bitcoin options market.
- A ruling in CME's favor would shift regulatory authority for this product category toward the CFTC and away from the SEC.
WASHINGTON, Aug. 3. The Securities and Exchange Commission has kept Nasdaq's bitcoin options on hold while approving a separate review for the Chicago Mercantile Exchange over contracts in the same asset class. CME is arguing the products are commodity option swaps subject exclusively to Commodity Futures Trading Commission oversight, a stance that would remove the SEC from any regulatory role over them.
What CME is arguing
CME's case centers on classification. Commodity option swaps fall under the Commodity Exchange Act and CFTC authority. If CME's contracts fit that definition, the SEC has no jurisdictional foothold. The exchange is telling regulators its bitcoin options belong in a statutory category that the SEC does not govern.
That distinction carries practical weight. The CFTC and SEC operate under separate statutes with different standards for margin requirements, reporting obligations, and market oversight. Which agency governs a product determines the rulebook that applies to how it is traded and cleared.
Nasdaq held while CME moves forward
The SEC advanced CME's review while keeping Nasdaq's bitcoin options frozen. The agency has not publicly explained the basis for treating the two cases differently or offered any timeline for Nasdaq's application.
For the $BTC options market, the CME proceeding now functions as a reference point. If the SEC accepts CME's commodity-swap argument and the CFTC takes authority over those contracts, the outcome shapes how regulators classify bitcoin options across exchanges. Nasdaq's application would follow whatever precedent the CME review produces.
The SEC and CFTC have each asserted authority over different segments of the crypto derivatives market. A ruling in CME's favor would shift the balance toward the CFTC for this product category and away from the SEC's reach.